Copyright Reports & Markets. All rights reserved.

Global and Japan Oral Anticoagulant Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Oral Anticoagulant Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Oral Anticoagulant Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Oral Anticoagulant Market Size Growth Rate by Type
    • 1.4.2 Warfarin
    • 1.4.3 Dabigatran
    • 1.4.4 Rivaroxaban
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Oral Anticoagulant Market Size Growth Rate by Application
    • 1.5.2 Thromboembolic Disease
    • 1.5.3 Disseminated Intravascular Coagulation
    • 1.5.4 Cardiovascular Surgery
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Oral Anticoagulant Market Size, Estimates and Forecasts
    • 2.1.1 Global Oral Anticoagulant Revenue 2015-2026
    • 2.1.2 Global Oral Anticoagulant Sales 2015-2026
  • 2.2 Global Oral Anticoagulant, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Oral Anticoagulant Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Oral Anticoagulant Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Oral Anticoagulant Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Oral Anticoagulant Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Oral Anticoagulant Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Oral Anticoagulant Revenue Forecast by Region (2021-2026)

3 Global Oral Anticoagulant Competitor Landscape by Players

  • 3.1 Global Top Oral Anticoagulant Sales by Manufacturers
    • 3.1.1 Global Oral Anticoagulant Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Oral Anticoagulant Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Oral Anticoagulant Manufacturers by Revenue
    • 3.2.1 Global Oral Anticoagulant Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Oral Anticoagulant Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Oral Anticoagulant Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Oral Anticoagulant Revenue in 2019
    • 3.2.5 Global Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Oral Anticoagulant Price by Manufacturers
  • 3.4 Global Oral Anticoagulant Manufacturing Base Distribution, Product Types
    • 3.4.1 Oral Anticoagulant Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Oral Anticoagulant Product Type
    • 3.4.3 Date of International Manufacturers Enter into Oral Anticoagulant Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Oral Anticoagulant Market Size by Type (2015-2020)
    • 4.1.1 Global Oral Anticoagulant Sales by Type (2015-2020)
    • 4.1.2 Global Oral Anticoagulant Revenue by Type (2015-2020)
    • 4.1.3 Oral Anticoagulant Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Oral Anticoagulant Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Oral Anticoagulant Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Oral Anticoagulant Revenue Forecast by Type (2021-2026)
    • 4.2.3 Oral Anticoagulant Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Oral Anticoagulant Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Oral Anticoagulant Market Size by Application (2015-2020)
    • 5.1.1 Global Oral Anticoagulant Sales by Application (2015-2020)
    • 5.1.2 Global Oral Anticoagulant Revenue by Application (2015-2020)
    • 5.1.3 Oral Anticoagulant Price by Application (2015-2020)
  • 5.2 Oral Anticoagulant Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Oral Anticoagulant Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Oral Anticoagulant Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Oral Anticoagulant Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

  • 6.1 Japan Oral Anticoagulant Market Size YoY Growth 2015-2026
    • 6.1.1 Japan Oral Anticoagulant Sales YoY Growth 2015-2026
    • 6.1.2 Japan Oral Anticoagulant Revenue YoY Growth 2015-2026
    • 6.1.3 Japan Oral Anticoagulant Market Share in Global Market 2015-2026
  • 6.2 Japan Oral Anticoagulant Market Size by Players (International and Local Players)
    • 6.2.1 Japan Top Oral Anticoagulant Players by Sales (2015-2020)
    • 6.2.2 Japan Top Oral Anticoagulant Players by Revenue (2015-2020)
  • 6.3 Japan Oral Anticoagulant Historic Market Review by Type (2015-2020)
    • 6.3.1 Japan Oral Anticoagulant Sales Market Share by Type (2015-2020)
    • 6.3.2 Japan Oral Anticoagulant Revenue Market Share by Type (2015-2020)
    • 6.3.3 Japan Oral Anticoagulant Price by Type (2015-2020)
  • 6.4 Japan Oral Anticoagulant Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 Japan Oral Anticoagulant Sales Forecast by Type (2021-2026)
    • 6.4.2 Japan Oral Anticoagulant Revenue Forecast by Type (2021-2026)
    • 6.4.3 Japan Oral Anticoagulant Price Forecast by Type (2021-2026)
  • 6.5 Japan Oral Anticoagulant Historic Market Review by Application (2015-2020)
    • 6.5.1 Japan Oral Anticoagulant Sales Market Share by Application (2015-2020)
    • 6.5.2 Japan Oral Anticoagulant Revenue Market Share by Application (2015-2020)
    • 6.5.3 Japan Oral Anticoagulant Price by Application (2015-2020)
  • 6.6 Japan Oral Anticoagulant Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 Japan Oral Anticoagulant Sales Forecast by Application (2021-2026)
    • 6.6.2 Japan Oral Anticoagulant Revenue Forecast by Application (2021-2026)
    • 6.6.3 Japan Oral Anticoagulant Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Oral Anticoagulant Market Size YoY Growth 2015-2026
  • 7.2 North America Oral Anticoagulant Market Facts & Figures by Country
    • 7.2.1 North America Oral Anticoagulant Sales by Country (2015-2020)
    • 7.2.2 North America Oral Anticoagulant Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Oral Anticoagulant Market Size YoY Growth 2015-2026
  • 8.2 Europe Oral Anticoagulant Market Facts & Figures by Country
    • 8.2.1 Europe Oral Anticoagulant Sales by Country
    • 8.2.2 Europe Oral Anticoagulant Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Oral Anticoagulant Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Oral Anticoagulant Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Oral Anticoagulant Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Oral Anticoagulant Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Oral Anticoagulant Market Size YoY Growth 2015-2026
  • 10.2 Latin America Oral Anticoagulant Market Facts & Figures by Country
    • 10.2.1 Latin America Oral Anticoagulant Sales by Country
    • 10.2.2 Latin America Oral Anticoagulant Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Oral Anticoagulant Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Oral Anticoagulant Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Oral Anticoagulant Sales by Country
    • 11.2.2 Middle East and Africa Oral Anticoagulant Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Akers Biosciences
    • 12.1.1 Akers Biosciences Corporation Information
    • 12.1.2 Akers Biosciences Description and Business Overview
    • 12.1.3 Akers Biosciences Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Akers Biosciences Oral Anticoagulant Products Offered
    • 12.1.5 Akers Biosciences Recent Development
  • 12.2 Pfizer
    • 12.2.1 Pfizer Corporation Information
    • 12.2.2 Pfizer Description and Business Overview
    • 12.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Pfizer Oral Anticoagulant Products Offered
    • 12.2.5 Pfizer Recent Development
  • 12.3 Eisai
    • 12.3.1 Eisai Corporation Information
    • 12.3.2 Eisai Description and Business Overview
    • 12.3.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Eisai Oral Anticoagulant Products Offered
    • 12.3.5 Eisai Recent Development
  • 12.4 AstraZeneca
    • 12.4.1 AstraZeneca Corporation Information
    • 12.4.2 AstraZeneca Description and Business Overview
    • 12.4.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 AstraZeneca Oral Anticoagulant Products Offered
    • 12.4.5 AstraZeneca Recent Development
  • 12.5 Eli Lilly
    • 12.5.1 Eli Lilly Corporation Information
    • 12.5.2 Eli Lilly Description and Business Overview
    • 12.5.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Eli Lilly Oral Anticoagulant Products Offered
    • 12.5.5 Eli Lilly Recent Development
  • 12.6 Medicure
    • 12.6.1 Medicure Corporation Information
    • 12.6.2 Medicure Description and Business Overview
    • 12.6.3 Medicure Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Medicure Oral Anticoagulant Products Offered
    • 12.6.5 Medicure Recent Development
  • 12.7 GlaxoSmithKline
    • 12.7.1 GlaxoSmithKline Corporation Information
    • 12.7.2 GlaxoSmithKline Description and Business Overview
    • 12.7.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 GlaxoSmithKline Oral Anticoagulant Products Offered
    • 12.7.5 GlaxoSmithKline Recent Development
  • 12.8 Novartis AG
    • 12.8.1 Novartis AG Corporation Information
    • 12.8.2 Novartis AG Description and Business Overview
    • 12.8.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Novartis AG Oral Anticoagulant Products Offered
    • 12.8.5 Novartis AG Recent Development
  • 12.9 Sanofi
    • 12.9.1 Sanofi Corporation Information
    • 12.9.2 Sanofi Description and Business Overview
    • 12.9.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Sanofi Oral Anticoagulant Products Offered
    • 12.9.5 Sanofi Recent Development
  • 12.11 Akers Biosciences
    • 12.11.1 Akers Biosciences Corporation Information
    • 12.11.2 Akers Biosciences Description and Business Overview
    • 12.11.3 Akers Biosciences Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Akers Biosciences Oral Anticoagulant Products Offered
    • 12.11.5 Akers Biosciences Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Oral Anticoagulant Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Oral Anticoagulant Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Oral Anticoagulant market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Oral Anticoagulant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Oral Anticoagulant market is segmented into
    Warfarin
    Dabigatran
    Rivaroxaban
    Others

    Segment by Application, the Oral Anticoagulant market is segmented into
    Thromboembolic Disease
    Disseminated Intravascular Coagulation
    Cardiovascular Surgery
    Others

    Regional and Country-level Analysis
    The Oral Anticoagulant market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Oral Anticoagulant market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Oral Anticoagulant Market Share Analysis
    Oral Anticoagulant market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Anticoagulant business, the date to enter into the Oral Anticoagulant market, Oral Anticoagulant product introduction, recent developments, etc.
    The major vendors covered:
    Akers Biosciences
    Pfizer
    Eisai
    AstraZeneca
    Eli Lilly
    Medicure
    GlaxoSmithKline
    Novartis AG
    Sanofi

    Buy now